393 related articles for article (PubMed ID: 25449001)
1. Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010).
Silva RA; Sridhar J; Miller D; Wykoff CC; Flynn HW
Am J Ophthalmol; 2015 Feb; 159(2):257-64.e1. PubMed ID: 25449001
[TBL] [Abstract][Full Text] [Related]
2. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Marangon FB; Miller D; Giaconi JA; Alfonso EC
Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
[TBL] [Abstract][Full Text] [Related]
3. Exogenous fungal endophthalmitis: microbiology and clinical outcomes.
Wykoff CC; Flynn HW; Miller D; Scott IU; Alfonso EC
Ophthalmology; 2008 Sep; 115(9):1501-7, 1507.e1-2. PubMed ID: 18486220
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Sen P; Gopal L; Sen PR
Retina; 2006 Oct; 26(8):935-9. PubMed ID: 17031296
[TBL] [Abstract][Full Text] [Related]
5. Favorable Outcomes of Filamentous Fungal Endophthalmitis Following Aggressive Management.
Bui DK; Carvounis PE
J Ocul Pharmacol Ther; 2016 Nov; 32(9):623-630. PubMed ID: 27447804
[TBL] [Abstract][Full Text] [Related]
6. Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Narendran N; Balasubramaniam B; Johnson E; Dick A; Mayer E
Acta Ophthalmol; 2008 Aug; 86(5):525-32. PubMed ID: 18752527
[TBL] [Abstract][Full Text] [Related]
7. Late-onset post-traumatic Phaeoacremonium parasiticum endophthalmitis.
Huynh TK; Lee LR; Ellis D
Clin Exp Ophthalmol; 2007; 35(4):366-8. PubMed ID: 17539790
[TBL] [Abstract][Full Text] [Related]
8. Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases.
Schimel AM; Miller D; Flynn HW
Am J Ophthalmol; 2013 Jul; 156(1):50-52.e1. PubMed ID: 23540710
[TBL] [Abstract][Full Text] [Related]
9. Endophthalmitis associated with fungal keratitis and penetrating injuries in North China.
Liu MY; Zhang L; Yin XL; Sun SY
Eur J Ophthalmol; 2020 May; 30(3):455-461. PubMed ID: 30832500
[TBL] [Abstract][Full Text] [Related]
10. Exogenous endophthalmitis caused by amphotericin B-resistant Paecilomyces lilacinus: treatment options and visual outcomes.
Scott IU; Flynn HW; Miller D; Speights JW; Snip RC; Brod RD
Arch Ophthalmol; 2001 Jun; 119(6):916-9. PubMed ID: 11405851
[No Abstract] [Full Text] [Related]
11. Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review.
Moloney TP; Park J
Br J Ophthalmol; 2014 Nov; 98(11):1492-7. PubMed ID: 24939423
[TBL] [Abstract][Full Text] [Related]
12. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
[TBL] [Abstract][Full Text] [Related]
13. Endogenous endophthalmitis due to alternaria in an immunocompetent host.
Rao AG; Thool BA; Rao CV
Retina; 2004 Jun; 24(3):478-81. PubMed ID: 15187681
[No Abstract] [Full Text] [Related]
14. In vitro antifungal activity of fluconazole and voriconazole against non-Candida yeasts and yeast-like fungi clinical isolates.
Mandras N; Roana J; Scalas D; Fucale G; Allizond V; Banche G; Barbui A; Li Vigni N; Newell VA; Cuffini AM; Tullio V
New Microbiol; 2015 Oct; 38(4):583-7. PubMed ID: 26485018
[TBL] [Abstract][Full Text] [Related]
15. Treatment of presumed fungal endophthalmitis with oral fluconazole.
Zarbin MA; Becker E; Witcher J; Yamani A; Irvine AR
Ophthalmic Surg Lasers; 1996 Jul; 27(7):628-31. PubMed ID: 9240781
[TBL] [Abstract][Full Text] [Related]
16. Concentrated intravitreal amphotericin B in fungal endophthalmitis.
Payne JF; Keenum DG; Sternberg P; Thliveris A; Kala A; Olsen TW
Arch Ophthalmol; 2010 Dec; 128(12):1546-50. PubMed ID: 21149777
[TBL] [Abstract][Full Text] [Related]
17. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model.
Karagoz E; Ugan RA; Duzgun E; Cadirci E; Keles S; Uyanik MH; Yavan I; Turhan V
Curr Eye Res; 2017 Feb; 42(2):225-232. PubMed ID: 27348425
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
